We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · August 11, 2020

Glycated Hemoglobin Levels and Cardiovascular Outcomes in Patients With T2D and Cardiovascular Disease

European Journal of Heart Failure


Additional Info

European Journal of Heart Failure
Association Between Glycated Haemoglobin Levels and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Cardiovascular Disease: A Secondary Analysis of the TECOS Randomized Clinical Trial
Eur. J. Heart Fail 2020 Jul 04;[EPub Ahead of Print], FA McAlister, Y Zheng, CM Westerhout, JB Buse, E Standl, DK McGuire, F Van de Werf, JB Green, PW Armstrong, RR Holman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading